Status:
RECRUITING
Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient
Lead Sponsor:
Assiut University
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
Brief Summary
It is a cross sectional study aimed to correlate between PSA Levels and F-18 PSMA PET/CT Scan findings and to evaluate the impact of PET/CT findings on the patient management
Detailed Description
Prostate cancer (PC) is a prevalent malignancy that occurs primarily in old males, it is the third most common with regards of mortality (1,2). prostate-specific membrane antigen (PSMA) known as gluta...
Eligibility Criteria
Inclusion
- Male Patients with pathologically proven prostate cancer who will be referred to nuclear medicine unit to perform F18 PSMA for different indications
Exclusion
- Undifferentiated prostate cancer.
- Studies with motion artifacts, or those in which patient can't stay stable or calm during acquisition.
- Severely ill patients that hinder imaging.
Key Trial Info
Start Date :
January 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT06209853
Start Date
January 20 2024
End Date
April 1 2025
Last Update
July 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Egypt